Research paperA sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells
Introduction
The measurement of 51Cr-release from lysed target cells has been the gold standard to measure the cytotoxic function of activated CD8+ T cells and NK cells for over 3 decades (Boyle, 1968, Thorn et al., 1974). However, overall the 51Cr-release assay is rather insensitive and is also plagued with a number of safety and environmental limitations. In addition, the membrane leakage events measured by 51Cr-release and other “release” methods may only reflect the action of perforin, especially at high effector to target ratios and not the true apoptotic nature of target cell death in vivo involving granzymes (Bashford et al., 1988, Shiver and Henkart, 1991). Newer methods at enumerating antigen-specific CD8+ T-cells, such as intracellular cytokine staining, the ELISPOT assay, and staining for T-cells using HLA/MHC class I tetramers have been introduced as substitutes, but none of these approaches measures the ultimate cytolytic function of CTL and NK cells as 51chromium-release. Another approach for the measurement of CTL activity is using flow cytometry (FACS). A number of FACS-based and fluorimeter-based assays have been developed that mostly involve the detection of target cell lysis using the release of pre-loaded dyes or uptake of external dyes much like 51Cr-release (Mattis et al., 1997, Roden et al., 1999, Sheehy et al., 2001, Fischer et al., 2002, Kienzle et al., 2002, Betts et al., 2003, Hermans et al., 2004). Recently, the application of FACS to monitor products of apoptosis generated in CTL target cells, such as monitoring of Annexin V binding and the detection of caspase activity and caspase cleavage, have been introduced as an alternative to the membranolytic-based detection methods (Fischer et al., 2002, Jerome et al., 2003a, Jerome et al., 2003b).
The induction of apoptosis before the onset of membrane leakage is one of the hallmarks of the target cell killing. The role of Granzyme B, and more recently Granzyme A, in cleaving a number of proteins such as caspases and other downstream mediators of apoptosis in target cells has been well established (Pham and Ley, 1997, Lieberman, 2003, Trapani and Sutton, 2003). Caspases are key enzymes regulating the apoptotic program leading to DNA fragmentation in all mammalian cells. Although experiments using caspase inhibitors and cytoplasts have shown that caspase 3 and other caspases are not always needed for target cell death (Henkart et al., 1997, Lieberman, 2003), the cleavage of caspase 3 as a direct consequence of the insertion of perforin and granzymes into CTL target cells can nevertheless be used as a marker for antigen-specific CTL activity. Thus, the detection of caspase 3 cleavage and other early products of apoptosis (e.g., phosphorylated histones) in target cells using FACS may serve as useful alternative assay to 51Chromium (Cr)-release and methods measuring target cell membrane lysis. The caspase 3 cleavage assay has been proposed as an alternative CTL assay system recently (Jerome et al., 2003a, Jerome et al., 2003b). However, a comprehensive study on the versatility of the assay in different CTL/target cell combinations, its applicability to different human and murine systems, the sensitivity of the assay, and how it performs relative to other cell-mediated immune response assays such as IFN-γ ELISPOT, HLA/MHC tetramer/pentamer staining, and other FACS-based methods has not been done.
In the work presented here we optimized a FACS-based CTL assay using caspase 3 cleavage as a readout and tested its applicability to a wide variety of both human and murine systems immune responses. We also determined its performance in monitoring CD8+ T cell responses in comparison to 51Cr-release, IFN-γ ELISPOT, and HLA tetramer/pentamer staining in human and murine systems. In addition, we studied the sensitivity limits of the assay in monitoring rare antigen-specific CD8+ effector cells in highly diluted T-cell populations. Overall, the assay proved to be highly sensitive, reproducible, and applicable to a variety of CTL effector cell situations with a variety of different target cell types. The assay showed the same degree of specificity and precision as ELISPOT and 51Cr-release. Moreover, its sensitivity to enumerate antigen-specific T-cell activity in highly diluted samples of effector cells was comparable to HLA tetramer/pentamer-based methods.
Section snippets
Reagents and cell culture media
Anti-cleaved caspase 3 (reactive against both human and mouse forms) was phycoerythrin (PE)-labeled and purchased from BD Biosciences (Mississauga, ON). Anti-phospho-histone H2A.X-FITC was purchased from Upstate Cell Signaling Solutions (Lake Placid, NY). The cell tracker dye, DDAO-SE (CellTrace™ Far Red DDAO-SE) was obtained from Molecular Probes (Eugene, OR). All cell culture medium was from Invitrogen (Mississauga, ON). Cytokines (IL-2, IL-2, IL-12, and IL-6) were from R&D Systems
Assay procedure and choice of target cell tracking dye
One of the first issues we resolved is the problem of finding an effective target cell tracking dye that would not interfere with the caspase 3 signal during FACS analysis. To maximize sensitivity, we wanted to use a biotin-labeled primary anti-cleaved caspase 3 followed with a Strepavidin-PE counter-stain brightly fluorescing in the FL2 channel. As a result, we searched for a non-toxic cell tracker dye that would emit fluorescence in the far-red part of the spectrum detected by the FL4 channel
Discussion
We have developed a modified flow cytometry-based assay to determine CD8+ cytotoxic T cell activity based on measuring the extent of caspase 3 cleavage in target cells. The assay was applicable to a wide variety of human and murine immune responses, was suitable for detecting CD8+ T-cell activity following both peptide and viral vector vaccination in mice, showed a similar level of specificity as 51Cr release and ELISPOT analysis, and proved to be highly sensitive under conditions when
References (28)
- et al.
Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis
Immunity
(1998) - et al.
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
Journal of Immunological Methods
(2003) - et al.
Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy
Blood
(1997) - et al.
An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity
Journal of Immunological Methods
(2002) - et al.
Do CTL kill target cells by inducing apoptosis?
Seminars in Immunology
(1997) - et al.
The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo
Journal of Immunological Methods
(2004) - et al.
Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens
Journal of Immunological Methods
(1996) - et al.
The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers
Journal of Immunological Methods
(2002) - et al.
Analyzing cytotoxic T lymphocyte activity: a simple and reliable flow cytometry-based assay
Journal of Immunological Methods
(1997) - et al.
The role of granzyme B cluster proteases in cell-mediated cytotoxicity
Seminars in Immunology
(1997)
A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology
Journal of Immunological Methods
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis [erratum appears in J Immunol Methods 2001 Jun 1;252(1–2):219–20]
Journal of Immunological Methods
A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene
Cell
Importance of the P4′ residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop
Journal of Biological Chemistry
Cited by (73)
Selection and expression of CD40 single chain variable fragment by phage display and evaluation of tumor specific immune activation
2019, International ImmunopharmacologyA tetravalent single chain diabody (CD40/HER2) efficiently inhibits tumor proliferation through recruitment of T cells and anti-HER2 functions
2019, Molecular ImmunologyCitation Excerpt :Caspase-3 is a critical protease for activation in the early stage of apoptosis and is the final apoptotic executioner (Liu et al., 1997). In many studies (He et al., 2005; Jerome et al., 2003), Caspase-3 has been used as an indicator of CTL function. In this study, IHC staining of Caspase-3 demonstrated that Caspase-3 was abundantly expressed in the T6-17 cytoplasm after CD40 × HER2 ScDb or CD40 mAb treatment, which indicated that CD40 × HER2 ScDb could induce the apoptosis of 4T1 cells by stimulating CTLs.
Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapy
2018, CytotherapyCitation Excerpt :Killing of target cells is preceded by the activation of several intracellular pathways, which ultimately leads to apoptosis and cytolysis. Induction of apoptotic pathways downstream of both the cytotoxic route and the death receptor route includes activation (i.e., cleavage) of several caspases [80,104]. Because post-translational modifications can considerably influence caspase activity, the presence of cleaved caspase may nevertheless not be the best indication of induction of apoptotic pathways [105].
Assessing Cell-Mediated Immune Functions
2018, Comprehensive Toxicology: Third Edition